Eversept Partners LP reduced its stake in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 6.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,974,287 shares of the company’s stock after selling 202,357 shares during the period. Avantor accounts for about 1.2% of Eversept Partners LP’s holdings, making the stock its 22nd biggest position. Eversept Partners LP’s holdings in Avantor were worth $23,318,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently modified their holdings of AVTR. EverSource Wealth Advisors LLC raised its holdings in shares of Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after acquiring an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC acquired a new stake in shares of Avantor during the second quarter valued at $32,000. Private Trust Co. NA boosted its stake in shares of Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after acquiring an additional 875 shares during the last quarter. Los Angeles Capital Management LLC purchased a new stake in Avantor during the 4th quarter worth about $32,000. Finally, Osaic Holdings Inc. increased its position in Avantor by 60.9% during the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after purchasing an additional 1,064 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.
Avantor Stock Performance
Avantor stock opened at $11.79 on Tuesday. The firm has a market capitalization of $8.05 billion, a P/E ratio of -14.56, a PEG ratio of 6.37 and a beta of 0.94. The stock has a fifty day moving average price of $9.80 and a 200 day moving average price of $9.39. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68.
Wall Street Analyst Weigh In
Several brokerages recently weighed in on AVTR. UBS Group set a $8.00 target price on shares of Avantor in a research note on Wednesday, June 24th. Wolfe Research downgraded shares of Avantor to an “underperform” rating and set a $7.00 price target for the company. in a report on Monday, June 1st. Barclays lifted their price target on shares of Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, June 24th. Sanford C. Bernstein began coverage on shares of Avantor in a research report on Friday, June 26th. They issued a “market perform” rating and a $10.50 price objective for the company. Finally, Evercore set a $10.50 price objective on shares of Avantor in a research note on Monday, July 6th. Two investment analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus target price of $10.62.
Check Out Our Latest Stock Report on Avantor
Insider Transactions at Avantor
In related news, Director Simon Dingemans acquired 25,000 shares of the company’s stock in a transaction dated Friday, May 1st. The stock was bought at an average price of $8.14 per share, with a total value of $203,500.00. Following the purchase, the director directly owned 25,000 shares in the company, valued at $203,500. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gregory T. Lucier acquired 10,000 shares of the business’s stock in a transaction dated Friday, May 8th. The shares were bought at an average price of $8.32 per share, for a total transaction of $83,200.00. Following the completion of the acquisition, the director owned 60,000 shares in the company, valued at approximately $499,200. This trade represents a 20.00% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.28% of the company’s stock.
Avantor Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Stories
- Five stocks we like better than Avantor
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
